Proton Pump Inhibitors (PPIs) and Chronic Kidney Disease: Acute Interstitial Nephritis

The short answer

Proton pump inhibitors (PPIs) can cause acute interstitial nephritis (AIN), a form of inflammatory kidney injury, but this is an uncommon complication. It does not mean that everyone taking a PPI will develop kidney disease.

Common PPIs include omeprazole, pantoprazole, esomeprazole, lansoprazole, and rabeprazole. They reduce stomach acid and are widely used for conditions such as reflux, ulcers, and prevention of gastrointestinal bleeding in selected patients.

The kidney concern is mainly about drug-induced AIN, which can cause acute kidney injury (AKI). Long-term observational studies have also reported associations between PPI use and CKD, but these studies cannot establish that PPIs directly cause CKD in every person who takes them. The clearest kidney injury directly linked to PPIs is AIN. (PubMed)

What is acute interstitial nephritis?

Acute interstitial nephritis is inflammation of the kidney’s interstitial tissue, the area surrounding the kidney tubules.

It is often triggered by a medication or, less commonly, an infection or autoimmune condition.

With PPI-associated AIN, the immune system appears to react to the drug or a drug-related substance. The resulting inflammation can interfere with normal kidney function and cause a rise in creatinine.

This is different from ordinary CKD progression. AIN is an acute process, although kidney function may not always return completely if the injury is severe or recognized late.

Does taking a PPI mean you will develop CKD?

No.

This is where the title needs some qualification.

PPIs have been associated with CKD and CKD progression in several observational studies, but an association does not prove that the PPI itself caused the kidney disease. People taking PPIs may differ from non-users in important ways, including age, other illnesses, medications, and reasons for needing acid suppression.

See also  Blood Thinners in CKD: Managing Anticoagulation with Reduced Kidney Function

Recent observational research continues to report associations between PPI exposure and CKD outcomes, but these studies should not be interpreted as proof that PPIs directly cause CKD in every user. (PubMed)

PPI-induced AIN is a more clearly recognized kidney adverse effect.

What might PPI-related AIN look like?

The problem is that AIN often does not produce a classic set of symptoms.

Possible findings include:

  • A rising serum creatinine
  • Reduced eGFR
  • Fatigue or feeling unwell
  • Nausea
  • Reduced urine output in more significant AKI
  • Blood or white blood cells in the urine
  • Sometimes fever, rash, or joint symptoms

The classic combination of fever + rash + eosinophilia is not present in every case.

Therefore, someone can have PPI-associated AIN without realizing that anything is wrong until a blood test shows worsening kidney function.

A rising creatinine does not automatically prove PPI-related AIN

This distinction is important.

A rise in creatinine can occur because of many conditions, including:

  • Dehydration
  • Infection or sepsis
  • Low blood pressure
  • Urinary obstruction
  • Other medications
  • Heart problems
  • Existing CKD
  • Other forms of kidney disease

A clinician therefore looks at the pattern and timing rather than simply asking whether the patient takes a PPI.

For example:

Previous creatinine → current creatinine → size of change → timing → urine findings → other medications → recent illness

This helps distinguish possible AIN from other causes of AKI.

Why CKD makes the issue more important

Someone with CKD already has reduced kidney reserve.

If that person develops an additional episode of AKI, recovery may be incomplete, and AKI is associated with a higher subsequent risk of CKD progression. A large 2025 systematic review and meta-analysis found higher long-term risks of CKD and other adverse kidney outcomes among people who experienced AKI, although individual risk varies considerably. (PubMed)

See also  Phosphorus Binders Explained: Calcium-Based vs Non-Calcium Binders in CKD

That does not mean every person with CKD who takes a PPI will suffer additional kidney damage.

It means that unexplained worsening kidney function deserves proper evaluation rather than being automatically attributed to “CKD progression.”

How is PPI-associated AIN diagnosed?

There is no simple blood test that proves a PPI caused AIN.

Doctors may review:

  • Creatinine and eGFR trends
  • Urinalysis
  • Urine sediment
  • Medication history
  • Timing of kidney-function changes
  • Other possible causes of AKI

Sometimes a kidney biopsy is required when the diagnosis remains uncertain or when the result would change treatment.

Tests such as urine eosinophils are not reliable enough to independently establish or exclude AIN.

What happens if a PPI is suspected?

If a clinician believes a PPI may be causing AIN, the medication is generally reviewed and often discontinued under medical supervision, particularly when there is a strong clinical suspicion.

The important point is that patients should not stop a prescribed PPI on their own simply because they read that PPIs can affect the kidneys.

The PPI may have an important reason for being prescribed, and another approach may or may not be appropriate.

If AIN is suspected, the healthcare team also considers other potentially responsible medications and evaluates the severity of the kidney injury.

Can kidney function recover?

It can.

Drug-induced AIN may improve after the responsible medication is removed, particularly when recognized promptly. However, recovery is not guaranteed, and some patients can be left with persistent kidney impairment or fibrosis.

The outcome depends on factors such as:

  • Severity of AKI
  • Duration of kidney inflammation
  • Baseline kidney function
  • How quickly the suspected cause is addressed
  • Other illnesses
  • Whether permanent interstitial damage has developed
See also  Antibiotic Dosage Adjustments in CKD: Aminoglycosides, Vancomycin, and Renal Clearance

Treatment decisions, including whether corticosteroids are appropriate, require individualized medical assessment rather than an automatic rule for every patient.

What should someone with CKD do if taking a PPI?

If you have CKD and use a PPI, a sensible approach is medication review rather than panic.

Ask your clinician:

  1. Why am I taking this PPI?
  2. Is there still a clear reason for continuing it?
  3. What is my recent creatinine/eGFR compared with previous results?
  4. Could another medication or illness explain a change in kidney function?
  5. Do I need kidney-function monitoring?

Do not substitute an over-the-counter acid-reducing product or another medicine without discussing it with your healthcare professional.

When should kidney problems be evaluated promptly?

Seek medical attention if you have significant or rapidly worsening symptoms such as:

  • Very little or no urine
  • Severe weakness or confusion
  • Significant swelling
  • Shortness of breath
  • Persistent vomiting or dehydration
  • A known rapid rise in creatinine
  • Other signs of serious illness

Symptoms alone cannot diagnose AIN. Blood and urine testing are usually necessary.

Bottom line

PPIs can cause acute interstitial nephritis, but this is an uncommon adverse effect—not an inevitable consequence of taking a PPI.

The strongest established kidney concern is PPI-associated AIN causing AKI. The broader claim that PPIs directly cause CKD is less certain because much of the evidence comes from observational studies and can be affected by other differences between PPI users and non-users. (PubMed)

For someone with CKD, the practical response is not to fear every PPI. Instead, make sure there is a clear reason for treatment, review kidney-function trends when clinically appropriate, and investigate an unexplained rise in creatinine rather than assuming it is simply CKD progression.

Leave a Comment